Literature DB >> 1705895

Epitope mapping of human thyroglobulin reveals a central immunodominant region.

Y Malthièry1, M Henry, E Zanelli.   

Abstract

Thyroglobulin is the thyroid hormone precursor and the major antigen frequently involved in autoimmune diseases. The primary structure of human thyroglobulin is known but the spatial structure remains largely undetermined. By using fusion protein produced in prokaryotic system we have characterized seven short immunoreactive peptides carrying at least one epitope. None of them includes hormonogenic sites, but five are concentrated in the central part of the monomeric molecule, which thus emerges as the major immunogenic region of this protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705895     DOI: 10.1016/0014-5793(91)80146-t

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Iodination of human thyroglobulin (Tg) alters its immunoreactivity. I. Iodination alters multiple epitopes of human Tg.

Authors:  A M Saboori; N R Rose; H S Bresler; M Vladut-Talor; C L Burek
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

2.  Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis.

Authors:  A K Short; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

3.  Tryptic peptides of human thyroglobulin: I. Immunoreactivity with murine monoclonal antibodies.

Authors:  A M Saboori; C L Burek; N R Rose; H S Bresler; M Talor; R C Kuppers
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

4.  Tryptic peptides of human thyroglobulin: II. Immunoreactivity with sera from patients with thyroid diseases.

Authors:  A M Saboori; P Caturegli; N R Rose; S Mariotti; A Pinchera; C L Burek
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

Review 5.  Thyroid Autoantibodies Display both "Original Antigenic Sin" and Epitope Spreading.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.